Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-17

Clinical Trial Update: Zolpidem Postmarketing Study in Adolescent Patients With Insomnia [Phase 4]

View source ↗

Summary

A Phase 4 postmarketing trial evaluating zolpidem in adolescent patients with insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem (zolpidem)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Insomnia | Phase 4 | Status: COMPLETED